Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults

NCT02656160 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Sleep Apnea, Obstructive

Interventions

DRUG: Placebo
DRUG: Dalfampridine

Sponsor

Brigham and Women's Hospital